Axcelis Technologies, Inc.
ACLS
$132.19
$7.465.98%
Weiss Ratings | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Excellent | |||
Risk Index | Fair | |||
Risk Grade | C- | |||
Reward Grade | A+ | |||
Rating Factors | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Excellent | |||
Efficiency Index | Excellent | |||
Solvency Index | Excellent | |||
Total Return Index | Excellent | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 2.16 | |||
Price History | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.52% | |||
30-Day Total Return | 3.70% | |||
60-Day Total Return | 66.57% | |||
90-Day Total Return | 77.70% | |||
Year to Date Total Return | 69.04% | |||
1-Year Total Return | 62.90% | |||
2-Year Total Return | 253.17% | |||
3-Year Total Return | 624.33% | |||
5-Year Total Return | 437.36% | |||
52-Week High % Change | -8.54% | |||
52-Week Low % Change | 168.76% | |||
Price | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $136.38 | |||
52-Week Low Price | $46.41 | |||
52-Week Low Price (Date) | Jul 05, 2022 | |||
52-Week High Price (Date) | Mar 23, 2023 | |||
Valuation | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | $4.08B | |||
Enterprise Value | 3.71B | |||
Price/Earnings (TTM) | 22.83 | |||
Earnings Per Share (TTM) | 5.46 | |||
Earnings Per Share Growth | 88.78% | |||
Price/Earnings To Growth | 0.26 | |||
Price/Sales (TTM) | 4.51 | |||
Price/Book (Q) | 6.13 | |||
Enterprise Value/Revenue (TTM) | 4.03 | |||
Price | $132.19 | |||
Enterprise Value/EBITDA (TTM) | 16.65 | |||
Enterprise Value/EBIT | 17.46 | |||
Market Cap Category | Mid Cap | |||
Dividends and Shares | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 33.262M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 978 787 4000 | |||
Address | 108 Cherry Hill Drive Beverly, MA 01915-1088 | |||
Website | www.axcelis.com | |||
Country | United States | |||
Year Founded | 1978 | |||
Profitability | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 23.08% | |||
Profit Margin | 19.89% | |||
Management Effectiveness | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 15.02% | |||
Return on Equity | 30.36% | |||
Income Statement | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | $920.00M | |||
Total Revenue (TTM) | $920.00M | |||
Revenue Per Share | $27.66 | |||
Gross Profit (TTM) | $401.79M | |||
EBITDA (TTM) | $222.57M | |||
EBIT (TTM) | $212.36M | |||
Net Income (TTM) | $183.08M | |||
Net Income Avl. to Common (TTM) | $183.08M | |||
Total Revenue Growth (Q YOY) | 29.35% | |||
Earnings Growth (Q YOY) | 59.42% | |||
EPS Diluted (TTM) | $5.46 | |||
EPS Diluted Growth (Q YOY) | 62.57% | |||
Balance Sheet | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | $432.17M | |||
Cash Per Share (Q) | $12.99 | |||
Total Current Assets (Q) | $877.65M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | $667.26M | |||
Current Ratio (Q) | 3.537 | |||
Book Value Per Share (Q) | $20.36 | |||
Total Assets (Q) | $1.01B | |||
Total Current Liabilities (Q) | $248.13M | |||
Total Debt (Q) | $58.71M | |||
Total Liabilities (Q) | $346.39M | |||
Total Common Equity (Q) | $667.26M | |||
Cash Flow | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -$257.25M | |||
Cash from Financing (TTM) | -$65.48M | |||
Net Change in Cash (TTM) | -$109.33M | |||
Levered Free Cash Flow (TTM) | $119.55M | |||
Cash from Operations (TTM) | $215.61M | |||